{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:59:07Z","timestamp":1787061547393,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["21 1463 Pj"],"award-info":[{"award-number":["21 1463 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020651","name":"Cayman Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["K 146277"],"award-info":[{"award-number":["K 146277"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021-02214"],"award-info":[{"award-number":["2021-02214"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","award":["KAW 2019.0059"],"award-info":[{"award-number":["KAW 2019.0059"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijpddr.2024.100564","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T22:07:54Z","timestamp":1726265274000},"page":"100564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4561-8026","authenticated-orcid":false,"given":"Alvie","family":"Loufouma-Mbouaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Andor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-4501","authenticated-orcid":false,"given":"David","family":"Leitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-8978","authenticated-orcid":false,"given":"Jorge","family":"P\u00e9rez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S.J.","family":"Arn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Walochnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9499-412X","authenticated-orcid":false,"given":"Tania","family":"Mart\u00edn-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Issue 5","key":"10.1016\/j.ijpddr.2024.100564_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1550-7408.2005.00053.x","article-title":"The new higher level classification of eukaryotes with emphasis on the taxonomy of protists","volume":"52","author":"Adl","year":"2005","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2024.100564_bib2","article-title":"New drug target in protozoan parasites: the role of thioredoxin reductase","volume":"vol. 6","author":"Andrade","year":"2015"},{"key":"10.1016\/j.ijpddr.2024.100564_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejop.2020.125760","article-title":"Free-living amoebae and other neglected protistan pathogens: health emergency signals?","volume":"77","author":"Angelici","year":"2021","journal-title":"Eur. J. Protistol."},{"key":"10.1016\/j.ijpddr.2024.100564_bib4","first-page":"301","article-title":"Selective evaluation of thioredoxin reductase enzymatic activities","volume":"vol. 1661","author":"Arn\u00e9r","year":"2018"},{"key":"10.1016\/j.ijpddr.2024.100564_bib5","series-title":"Redox Chemistry and Biology of Thiols","first-page":"197","article-title":"Thioredoxin and glutathione reductases","author":"Arn\u00e9r","year":"2022"},{"key":"10.1016\/j.ijpddr.2024.100564_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpddr.2024.100564_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102719","article-title":"Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4","volume":"63","author":"Cheff","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijpddr.2024.100564_bib8","first-page":"95","article-title":"Expressing recombinant selenoproteins using redefinition of a single UAG codon in an RF1-depleted E. coli host strain","volume":"vol. 662","author":"Cheng","year":"2022"},{"key":"10.1016\/j.ijpddr.2024.100564_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102070","article-title":"Production and purification of homogenous recombinant human selenoproteins reveals a unique codon skipping event in E. coli and GPX4-specific affinity to bromosulfophthalein","volume":"46","author":"Cheng","year":"2021","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100564_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.06.009","article-title":"Acanthamoeba keratitis: diagnosis and treatment update 2009","volume":"148","author":"Dart","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ijpddr.2024.100564_bib11","first-page":"35","article-title":"Anti-trypanosomatid drug discovery: progress and challenges","volume":"vol. 21","author":"De Rycker","year":"2023"},{"key":"10.1016\/j.ijpddr.2024.100564_bib12","article-title":"Reactive oxygen species as the brainbox in malaria treatment","volume":"vol. 10","author":"Egwu","year":"2021"},{"key":"10.1016\/j.ijpddr.2024.100564_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.08.016","article-title":"Resistance to artemisinin in falciparum malaria parasites: a redox-mediated phenomenon","volume":"179","author":"Egwu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijpddr.2024.100564_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102278","article-title":"Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus","volume":"51","author":"Fata","year":"2022","journal-title":"Redox Biol."},{"issue":"21","key":"10.1016\/j.ijpddr.2024.100564_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215075","article-title":"Repurposing auranofin and evaluation of a new gold(I) compound for the search of treatment of human and cattle parasitic diseases: from Protozoa to helminth infections","volume":"25","author":"Feng","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2024.100564_bib16","first-page":"320","article-title":"Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases","volume":"vol. 190","author":"Gencheva","year":"2022"},{"key":"10.1016\/j.ijpddr.2024.100564_bib17","first-page":"382","article-title":"Human placenta thioredoxin reductase: preparation and inhibitor studies","volume":"vol. 347","author":"Gromer","year":"2002"},{"key":"10.1016\/j.ijpddr.2024.100564_bib18","first-page":"269","article-title":"Recent developments in structure-based drug design","volume":"vol. 78","author":"Klebe","year":"2000"},{"key":"10.1016\/j.ijpddr.2024.100564_bib19","doi-asserted-by":"crossref","DOI":"10.1051\/parasite\/2022025","article-title":"Transcriptional changes of proteins of the thioredoxin and glutathione systems in Acanthamoeba spp. under oxidative stress -an RNA approach","volume":"29","author":"K\u00f6hsler","year":"2022","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2024.100564_bib20","article-title":"An overview on target-based drug design against kinetoplastid protozoan infections: human african trypanosomiasis, chagas disease and leishmaniases","volume":"vol. 26","author":"Kourbeli","year":"2021"},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100564_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/anie.200300639","article-title":"Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia","volume":"44","author":"Krauth-Siegel","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.ijpddr.2024.100564_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1371\/journal.pmed.0040206","article-title":"Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target","volume":"4","author":"Kuntz","year":"2007","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.ijpddr.2024.100564_bib23","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1007\/s00018-021-03786-x","article-title":"An unusual thioredoxin system in the facultative parasite Acanthamoeba castellanii","volume":"78","author":"Leitsch","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijpddr.2024.100564_bib24","first-page":"576","article-title":"Redox pathways as drug targets in microaerophilic parasites","volume":"vol. 34","author":"Leitsch","year":"2018"},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100564_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80222-3","article-title":"Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years","volume":"11","author":"List","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2024.100564_bib26","article-title":"An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment","volume":"vol. 22","author":"Lorenzo-Morales","year":"2015"},{"issue":"12","key":"10.1016\/j.ijpddr.2024.100564_bib27","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/AAC.00329-10","article-title":"Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba","volume":"54","author":"Lorenzo-Morales","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100564_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106425","article-title":"Antimicrobial effect of auranofin against Acanthamoeba spp","volume":"58","author":"Loufouma Mbouaka","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2024.100564_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1175469","article-title":"Assessing Acanthamoeba cytotoxicity: comparison of common cell viability assays","volume":"14","author":"Loufouma Mbouaka","year":"2023","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.ijpddr.2024.100564_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/CMR.16.2.273-307.2003","article-title":"Acanthamoeba spp. as agents of disease in humans","volume":"16","author":"Marciano-Cabral","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100564_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10040491","article-title":"In vitro evaluation of the combination of melaleuca alternifolia (Tea tree) oil and dimethyl sulfoxide (DMSO) against trophozoites and cysts of acanthamoeba strains. oxygen consumption rate (OCR) assay as a method for drug screening","volume":"10","author":"Mart\u00edn-P\u00e9rez","year":"2021","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.ijpddr.2024.100564_bib32","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00436-019-06341-7","article-title":"Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini","volume":"118","author":"Mart\u00edn-P\u00e9rez","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2024.100564_bib33","author":"Maycock"},{"issue":"10","key":"10.1016\/j.ijpddr.2024.100564_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100564_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/aos.14337","article-title":"Increasing incidence of Acanthamoeba keratitis in a large tertiary ophthalmology department from year 1994 to 2018","volume":"98","author":"Nielsen","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpddr.2024.100564_bib36","doi-asserted-by":"crossref","DOI":"10.2174\/187152607782110059","article-title":"Drug targets from human pathogenic amoebas: entamoeba histolytica, acanthamoeba polyphaga and Naegleria fowleri","volume":"7","author":"Ondarza","year":"2007","journal-title":"Infect. Disord. - Drug Targets"},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100564_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/ars.2011.4436","article-title":"Redox-active antiparasitic drugs","volume":"17","author":"Pal","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"9","key":"10.1016\/j.ijpddr.2024.100564_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222092","article-title":"The rising incidence of Acanthamoeba keratitis: a 7-year nationwide survey and clinical assessment of risk factors and functional outcomes","volume":"14","author":"Randag","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100564_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exppara.2009.11.016","article-title":"Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections","volume":"126","author":"Roberts","year":"2010","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100564_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R"},{"key":"10.1016\/j.ijpddr.2024.100564_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102184","article-title":"Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin","volume":"48","author":"Sabatier","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100564_bib42","article-title":"Biology and pathogenesis of acanthamoeba","volume":"5","author":"Siddiqui","year":"2012","journal-title":"Parasites Vectors"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:40:34Z","timestamp":1778845234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320724000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":42,"alternative-id":["S2211320724000459"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100564","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100564"}}